Tenet Healthcare (THC) Return on Capital Employed (2010 - 2026)

Tenet Healthcare (THC) has 17 years of Return on Capital Employed data on file, last reported at 15.9% in Q1 2026.

• Quarterly Return on Capital Employed rose 123.0% year-over-year to 15.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.9% (up 123.0% YoY) and the FY2025 annual result came in at 14.12%, down 1038.0% from the prior year.
• Return on Capital Employed improved to 15.9% in Q1 2026 per THC's latest filing, from 13.98% in the prior quarter.
• The five-year high for Return on Capital Employed was 24.68% in Q3 2024, with the low at 8.76% in Q4 2022.
• Average Return on Capital Employed over 5 years is 14.91%, with a median of 13.98% recorded in 2025.
• Year-over-year, Return on Capital Employed soared 1484 bps in 2024 and plunged 1050 bps in 2025.
• Tenet Healthcare's Return on Capital Employed stood at 8.76% in 2022, then increased by 4 bps to 9.13% in 2023, then surged by 163 bps to 23.97% in 2024, then tumbled by 42 bps to 13.98% in 2025, then rose by 14 bps to 15.9% in 2026.
• Business Quant data shows THC's Return on Capital Employed at 15.9% in Q1 2026, 13.98% in Q4 2025, and 14.19% in Q3 2025.